ConvaTec Group PLC (CTEC)
Industry Medical Instruments & Supplies
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
262.40p
Buy
262.60p
47.80p (+22.07%)
Prices updated at 12 Nov 2024, 16:49 GMT
| Prices minimum 15 mins delay
Prices in GBX
ConvaTec Group PLC is a medical products and technologies company focused on therapies for the management of chronic conditions offering wound care, ostomy care, continence and critical care, and infusion devices.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Most recent dividend payment
0.014 | |
Cash Dividend | |
22 Aug 2024 | |
30 Jul 2024 | |
23 Aug 2024 | |
04 Oct 2024 |
Total dividend yield
Dividend history and forecast data table
Year | Dividend per share | Dividend growth (%) |
---|---|---|
2024 | 0.0494 | - |
2023 | 0.0504 | 0.08 |
2022 | 0.0457 | 0.03 |
2021 | 0.0407 | 0.01 |
2020 | 0.0440 | -0.03 |
2019 | 0.0450 | -0.05 |
2018 | 0.0440 | 3.41 |
2017 | 0.0106 | - |
2016 | - | - |
Total dividend yield data table
Year | Dividend yield (%) | Buyback yield (%) |
---|---|---|
2024 | 2.18 | - |
2023 | 2.06 | - |
2022 | 1.97 | - |
2021 | 2.11 | - |
2020 | 2.21 | - |
2019 | 2.27 | - |
2018 | 3.17 | - |
2017 | 0.52 | - |
2016 | - | - |
Dividend per share
% of earnings paid to shareholders
Dividend per share data table
Year | Dividend per share |
---|---|
2024 | 0.0494 |
2023 | 0.0504 |
2022 | 0.0457 |
2021 | 0.0407 |
2020 | 0.0440 |
2019 | 0.0450 |
2018 | 0.0440 |
2017 | 0.0106 |
2016 | - |
% of earnings paid to shareholders data table
Year | Payout ratio (%) |
---|---|
2024 | 83.40 |
2023 | 181.54 |
2022 | 146.08 |
2021 | 83.15 |
2020 | 370.27 |
2019 | 71.78 |
2018 | 47.55 |
2017 | - |
2016 | - |
Latest Financial Report as of 11 Nov 2024
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.